Re-engineering CNS drug discovery and development using computer aided modeling

Author:

Hugo Geerts

Publication Date: November 23, 2020
Journal: In Silico Pharmacology

Translating biological knowledge into useful therapeutic interventions for patients is a steep challenge. Of all the indications, Neurology and Psychiatry rank among the lowest in success rate for clinical development likely because the brain is an extremely complex organ with many non-linear feedback circuits. In addition, the brain is not accessible to the same extent as other organs and biomarkers are limited.